Resistance to Immune Checkpoint Inhibitors. Next Steps and Combinational Approaches

Memo - Magazine of European Medical Oncology - Austria
doi 10.1007/s12254-019-0493-6
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Immune Checkpoint Inhibitors and irAEs

Trends in Immunotherapy
2018English

Hyperprogression and Immune Checkpoint Inhibitors: Hype or Progress?

Oncologist
Cancer ResearchMedicineOncology
2019English

Immune Checkpoint Inhibitors in Melanoma: Review and Update

Journal of the Portuguese Society of Dermatology and Venereology
2018English

Immune Checkpoint Inhibitors for Metastatic Bladder Cancer

Cancer Treatment Reviews
MedicineOncologyRadiologyNuclear MedicineImaging
2018English

Survival Outcomes Following Combination Radiotherapy and Immune Checkpoint Inhibitors

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2017English

Overview of Immune Checkpoint Inhibitors Therapy for Hepatocellular Carcinoma, and the ITA.LI.CA Cohort Derived Estimate of Amenability Rate to Immune Checkpoint Inhibitors in Clinical Practice

Cancers
Cancer ResearchOncology
2019English

Update on Immune Checkpoint Inhibitors in Gynecological Cancers

Journal of Gynecologic Oncology
MedicineGynecologyOncologyObstetrics
2017English

Resistance Mechanisms in Melanoma to Immuneoncologic Therapy With Checkpoint Inhibitors

2019English

Review of Cancer Treatment With Immune Checkpoint Inhibitors

Wiener Klinische Wochenschrift
Medicine
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy